|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hamashima C, Shabana M, Okada K, Okamoto M
and Osaki Y: Mortality reduction from gastric cancer by endoscopic
and radiographic screening. Cancer Sci. 106:1744–1749. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Warburg O: On respiratory impairment in
cancer cells. Science. 124:269–270. 1956.PubMed/NCBI
|
|
6
|
Bresters TW, de Kok A and Veeger C: The
pyruvate-dehydrogenase complex from Azotobacter vinelandii.
2. Regulation of the activity. Eur J Biochem. 59:347–353. 1975.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim JW, Tchernyshyov I, Semenza GL and
Dang CV: HIF-1-mediated expression of pyruvate dehydrogenase
kinase: A metabolic switch required for cellular adaptation to
hypoxia. Cell Metab. 3:177–185. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dupuy F, Tabaries S, Andrzejewski S, Dong
Z, Blagih J, Annis MG, Omeroglu A, Gao D, Leung S, Amir E, et al:
PDK1-dependent metabolic reprogramming dictates metastatic
potential in breast cancer. Cell Metab. 22:577–589. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Y, Li X, Zhong Y, Ji Y, Yu D, Zhang M,
Wen JG, Zhang H, Goscinski MA, Nesland JM, et al: PDHA1 gene
knockout in prostate cancer cells results in metabolic
reprogramming towards greater glutamine dependence. Oncotarget.
7:53837–53852. 2016.PubMed/NCBI
|
|
10
|
Liu F, Zhang W, You X, Liu Y, Li Y, Wang
Z, Wang Y, Zhang X and Ye L: The oncoprotein HBXIP promotes glucose
metabolism reprogramming via downregulating SCO2 and PDHA1 in
breast cancer. Oncotarget. 6:27199–27213. 2015.PubMed/NCBI
|
|
11
|
Li Y, Huang R, Li X, Li X, Yu D, Zhang M,
Wen J, Goscinski MA, Trope CG, Nesland JM, et al: Decreased
expression of pyruvate dehydrogenase A1 predicts an unfavorable
prognosis in ovarian carcinoma. Am J Cancer Res. 6:2076–2087.
2016.PubMed/NCBI
|
|
12
|
Lin CS, Lee HT, Lee MH, Pan SC, Ke CY,
Chiu AW and Wei YH: Role of mitochondrial DNA copy number
alteration in human renal cell carcinoma. Int J Mol Sci.
17:E8142016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hao NB, He YF, Li XQ, Wang K and Wang RL:
The role of miRNA and lncRNA in gastric cancer. Oncotarget.
8:81572–81582. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bartels CL and Tsongalis GJ: MicroRNAs:
Novel biomarkers for human cancer. Clin Chem. 55:623–631. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lai WF and Siu PM: MicroRNAs as regulators
of cutaneous wound healing. J Biosci. 39:519–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Farh KK, Grimson A, Jan C, Lewis BP,
Johnston WK, Lim LP, Burge CB and Bartel DP: The widespread impact
of mammalian MicroRNAs on mRNA repression and evolution. Science.
310:1817–1821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yi R, O'Carroll D, Pasolli HA, Zhang Z,
Dietrich FS, Tarakhovsky A and Fuchs E: Morphogenesis in skin is
governed by discrete sets of differentially expressed microRNAs.
Nat Genet. 38:356–362. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Masoudi MS, Mehrabian E and Mirzaei H:
MiR-21: A key player in glioblastoma pathogenesis. J Cell Biochem.
119:1285–1290. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han JG, Jiang YD, Zhang CH, Yang YM, Pang
D, Song YN and Zhang GQ: A novel panel of serum
miR-21/miR-155/miR-365 as a potential diagnostic biomarker for
breast cancer. Ann Surg Treat Res. 92:55–66. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sekar D, Krishnan R, Thirugnanasambantham
K, Rajasekaran B, Islam VI and Sekar P: Significance of microRNA 21
in gastric cancer. Clin Res Hepatol Gastroenterol. 40:538–545.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang P, Guan Q, Zhou D, Yu Z, Song Y and
Qiu W: miR-21 inhibitors modulate biological functions of gastric
cancer cells via PTEN/PI3K/mTOR Pathway. DNA Cell Biol. 37:38–45.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shen KH, Hung JH, Chang CW, Weng YT, Wu MJ
and Chen PS: Solasodine inhibits invasion of human lung cancer cell
through downregulation of miR-21 and MMPs expression. Chem Biol
Interact. 268:129–135. 2017. View Article : Google Scholar : PubMed/NCBI
|
